Filing metadata

Accession number
0001415889-25-013869
Form type
Form 4
Filer
KalVista Pharmaceuticals, Inc.
CIK
CIK 1348911
Filed
May 20, 2025
Reporting period
May 17, 2025
Description
Insider transaction

Explore SEC Filings Hub